Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Radical Pleurectomy/decortication And Intraoperative Radiotherapy Followed By Conformal Radiation With Or Without Chemotherapy For Malignant Pleural Mesothelioma.

T. T. Lee, Darcie L. Everett, H. Shu, T. Jahan, M. Roach, J. Speight, R. Cameron, T. Phillips, A. Chan, D. Jablons
Published 2002 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
OBJECTIVES We performed a retrospective review of the efficacy and morbidity of radical pleurectomy/decortication and intraoperative radiotherapy followed by external beam radiation therapy with or without chemotherapy for diffuse malignant pleural mesothelioma. METHODS A total of 32 patients with diffuse malignant pleural mesothelioma were initially evaluated between January 1995 and September 2000. Three patients were excluded from analysis because of unresectable disease. Two patients died postoperatively, and one patient had recurrent disease previously treated at an outside institution. Of the remaining 26 patients included in the analysis, 24 received intraoperative radiotherapy. External beam radiation therapy was generally started 1 to 2 months after resection and delivered by means of 3-dimensional conformal radiation therapy or with inverse treatment planning intensity-modulated radiation therapy. When given, chemotherapy consisted of 2 to 3 cycles of cyclophosphamide, doxorubicin (Adriamycin), and cisplatin initiated 1 to 2 months after completion of radiation. RESULTS At the time of data analysis, 5 of 26 patients were alive. The median follow-up was 9.7 months (range, 2-67.6 months). The median overall survival and progression-free interval from the time of the operation were 18.1 and 12.2 months, respectively. The Kaplan-Meier estimates of overall survival and freedom from progression at 1 year were 64% and 50%, respectively. The site of failure was mostly locoregional. However, there were 4 abdominal failures and 1 contralateral lung failure. CONCLUSIONS Radical pleurectomy/decortication with aggressive radiotherapy with or without chemotherapy might offer an alternative treatment option to those who cannot tolerate extrapleural pneumonectomy.



This paper is referenced by
10.1634/theoncologist.2010-0185
What is the role of radiotherapy in malignant pleural mesothelioma?
A. Price (2011)
10.1007/s11748-014-0389-7
Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma
S. Hasegawa (2014)
10.1097/JTO.0b013e3181f1cf2b
Malignant Pleural Mesothelioma: A Population-Based Study of Survival
M. Milano (2010)
10.1097/JTO.0b013e31815608d9
Prognostic Factors in the Treatment of Malignant Pleural Mesothelioma at a Large Tertiary Referral Center
R. Flores (2007)
10.1136/thx.2007.087619
BTS statement on malignant mesothelioma in the UK, 2007
(2007)
10.1097/JTO.0000000000000064
Does Surgery Improve Survival of Patients with Malignant Pleural Mesothelioma?: A Multicenter Retrospective Analysis of 1365 Consecutive Patients
P. Bovolato (2014)
10.1016/j.ejcts.2010.02.012
May cyclooxygenase-2 (COX-2), p21 and p27 expression affect prognosis and therapeutic strategy of patients with malignant pleural mesothelioma?
T. Mineo (2010)
10.21037/jtd.2018.01.116
Pleurectomy/decortication versus extrapleural pneumonectomy: a critical choice.
P. Filosso (2018)
10.1111/1759-7714.12008
Role of new radiation techniques in the treatment of pleural mesothelioma
M. Amichetti (2013)
10.1080/17476348.2017.1338951
Induction chemotherapy vs post-operative adjuvant therapy for malignant pleural mesothelioma
G. Marulli (2017)
10.1097/JTO.0b013e318031d05c
Four-Modality Therapy in Malignant Pleural Mesothelioma: A Phase II Study
M. Lucchi (2007)
10.1177/107327480601300402
Malignant pleural mesothelioma: a comprehensive review.
R. Ismail-Khan (2006)
10.1007/s10903-020-01038-x
Racial Disparities in Treatment Patterns and Survival Among Surgically Treated Malignant Pleural Mesothelioma Patients
N. Alpert (2020)
10.1007/s12307-010-0048-1
Kinetics of Host Cell Recruitment During Dissemination of Diffuse Malignant Peritoneal Mesothelioma
N. Miselis (2010)
10.2174/1876533501306010010
Progress in Radical Surgery for Malignant Pleural Mesothelioma
L. Politi (2013)
10.1097/JTO.0b013e3182199819
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma
A. Chi (2011)
10.1007/s13244-015-0441-x
Imaging characteristics of pleural tumours
L. De Paoli (2015)
10.1097/JTO.0b013e3182288af9
Pleurectomy/Decortication, Hyperthermic Pleural Lavage with Povidone-Iodine Followed by Adjuvant Chemotherapy in Patients with Malignant Pleural Mesothelioma
L. Lang-Lazdunski (2011)
10.1111/j.1440-1843.2005.00714.x
Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma
D. Sterman (2005)
10.18632/oncotarget.22062
Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis
Z. Zhao (2017)
10.1179/oeh.2004.10.1.26
Malignant Pleural Mesothelioma—An Update
D. Stewart (2004)
10.1097/JTO.0b013e3181f1903e
Frequency of Use and Predictors of Cancer-Directed Surgery in the Management of Malignant Pleural Mesothelioma in a Community-Based (Surveillance, Epidemiology, and End Results [SEER]) Population
R. Flores (2010)
10.1097/JTO.0b013e31818b174d
Treatment of Malignant Pleural Mesothelioma with Carboplatin, Liposomized Doxorubicin, and Gemcitabine: A Phase II Study
G. Hillerdal (2008)
Semantic Scholar Logo Some data provided by SemanticScholar